Free Trial

Arlington Partners LLC Sells 4,559 Shares of Corteva, Inc. (NYSE:CTVA)

Corteva logo with Consumer Staples background

Arlington Partners LLC lowered its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 6.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 71,362 shares of the company's stock after selling 4,559 shares during the period. Corteva accounts for approximately 1.8% of Arlington Partners LLC's investment portfolio, making the stock its 19th biggest holding. Arlington Partners LLC's holdings in Corteva were worth $4,491,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in CTVA. Golden State Wealth Management LLC increased its holdings in shares of Corteva by 322.7% during the first quarter. Golden State Wealth Management LLC now owns 2,388 shares of the company's stock worth $150,000 after purchasing an additional 1,823 shares during the period. Bessemer Group Inc. increased its position in shares of Corteva by 17.0% in the first quarter. Bessemer Group Inc. now owns 3,616,067 shares of the company's stock worth $227,559,000 after purchasing an additional 525,228 shares during the period. Mill Capital Management LLC bought a new position in shares of Corteva in the first quarter worth $214,000. Legacy Advisors LLC increased its holdings in Corteva by 2.2% in the 1st quarter. Legacy Advisors LLC now owns 8,697 shares of the company's stock valued at $547,000 after buying an additional 188 shares during the period. Finally, Asset Management One Co. Ltd. increased its stake in Corteva by 26.5% in the first quarter. Asset Management One Co. Ltd. now owns 334,294 shares of the company's stock valued at $21,037,000 after acquiring an additional 70,025 shares during the last quarter. Institutional investors own 81.54% of the company's stock.

Corteva Price Performance

CTVA stock opened at $73.37 on Wednesday. The company's 50-day moving average is $67.70 and its 200-day moving average is $63.09. The stock has a market capitalization of $50.05 billion, a PE ratio of 44.74, a price-to-earnings-growth ratio of 1.90 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.44 and a quick ratio of 1.00. Corteva, Inc. has a 1 year low of $50.30 and a 1 year high of $74.96.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $1.13 earnings per share for the quarter, beating analysts' consensus estimates of $0.88 by $0.25. Corteva had a net margin of 6.77% and a return on equity of 7.84%. The firm had revenue of $4.42 billion for the quarter, compared to analyst estimates of $4.56 billion. During the same period last year, the firm earned $0.89 earnings per share. The business's quarterly revenue was down 1.7% compared to the same quarter last year. Equities research analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Friday, May 2nd were paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.93%. The ex-dividend date of this dividend was Monday, June 2nd. Corteva's dividend payout ratio (DPR) is presently 41.46%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CTVA shares. Oppenheimer reiterated an "outperform" rating and issued a $75.00 price target (up previously from $72.00) on shares of Corteva in a research note on Friday, May 9th. Morgan Stanley boosted their price objective on Corteva from $65.00 to $71.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Jefferies Financial Group restated a "buy" rating on shares of Corteva in a report on Friday, June 6th. UBS Group boosted their price target on Corteva from $74.00 to $76.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Finally, KeyCorp boosted their target price on shares of Corteva from $71.00 to $72.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Three research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $72.08.

Check Out Our Latest Report on CTVA

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Recommended Stories

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Corteva Right Now?

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines